Inventor · disambiguated record
Bertram Cezanne
Also filed as: CEZANNE BERTRAM
25 granted patents·16 pending applications·87 citations·filing 1999–2010
94Inventor score
Top patents by PatentIndex Score
41 records- 0183US8153649B23-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetesKLEIN MARKUS·Filed 2007·Granted Apr 10, 2012·4 cites·27 claims
- 0283US7906516B2Carbonyl compoundsMERCK PATENT GMBH·Filed 2004·Granted Mar 15, 2011·17 cites·28 claims
- 0380US7273867B2Phenyl derivativesMERCK PATENT GMBH·Filed 2001·Granted Sep 25, 2007·14 cites·14 claims
- 0478US8129373B2Carbonyl compoundsTSAKLAKIDIS CHRISTOS·Filed 2010·Granted Mar 6, 2012·5 cites·43 claims
- 0577US7977343B2Adenine derivativesMERCK PATENT GMBH·Filed 2006·Granted Jul 12, 2011·3 cites·14 claims
- 0675US7683093B2Prolinyl derivatives for the treatment of thrombosisMERCK PATENT GMBH·Filed 2005·Granted Mar 23, 2010·2 cites·20 claims
- 0774US7199133B2Derivatives of phenoxy-n-′4-(isothiazolindin-1, 1-dioxid-2yl)phenyll-valerian-acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumorsMERCK PATENT GMBH·Filed 2002·Granted Apr 3, 2007·8 cites·15 claims
- 0873US6943179B2Biurethane derivativesMERCK PATENT GMBH·Filed 2002·Granted Sep 13, 2005·7 cites·21 claims
- 0970US8258151B23-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitorsMEDERSKI WERNER·Filed 2007·Granted Sep 4, 2012·1 cites·9 claims
- 1069US7183277B2Carboxylic acid amidesMERCK PATENT GMBH·Filed 2003·Granted Feb 27, 2007·4 cites·27 claims
- 1165US7951804B2Piperidinyl compoundsMERCK PATENT GMBH·Filed 2004·Granted May 31, 2011·2 cites·39 claims
- 1265US7598241B2Carboxamide derivatives and their use as factor Xa inhibitorsMERCK PATENT GMBH·Filed 2004·Granted Oct 6, 2009·2 cites·33 claims
- 1365US7566789B2Benzimidazole derivativesMERCK PATENT GMBH·Filed 2003·Granted Jul 28, 2009·2 cites·18 claims
- 1465US7557222B21-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosisMERCK PATENT GMBH·Filed 2004·Granted Jul 7, 2009·2 cites·15 claims
- 1562US7579346B2CarboxamidesMERCK PATENT GMBH·Filed 2003·Granted Aug 25, 2009·1 cites·25 claims
- 1662US7557102B2Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thrombosesMERCK PATENT GMBH·Filed 2004·Granted Jul 7, 2009·1 cites·14 claims
- 1754US7687624B2Process for the production of N-arylmorpholinonesMERCK PATENT GMBH·Filed 2004·Granted Mar 30, 2010·0 cites·13 claims
- 1854US6441013B1Sulphonyloxazolamines as therapeutic active ingredientsMERCK PATENT GMBH·Filed 1999·Granted Aug 27, 2002·12 cites·7 claims
- 1949US7732481B2ProlinylarylacetamidesMERCK PATENT GMBH·Filed 2004·Granted Jun 8, 2010·0 cites·23 claims
- 2049US2005137230A1Carboxamide derivativesFiled 2005·Application pending·0 cites
- 2147US8119675B2Benzimidazole derivativesBURGDORF LARS THORE·Filed 2008·Granted Feb 21, 2012·0 cites·19 claims
- 2247US7763611B2Aroylsemicarbazide derivatives against thromboembolic diseasesMERCK PATENT GMBH·Filed 2004·Granted Jul 27, 2010·0 cites·14 claims
- 2346US7504500B2Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate productsMERCK PATENT GMBH·Filed 2004·Granted Mar 17, 2009·0 cites·20 claims
- 2446US7427618B2Ethynyl derivatives as factor Xa inhibitorsMERCK PATENT GMBH·Filed 2004·Granted Sep 23, 2008·0 cites·18 claims
- 2546US2004038858A1Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumoursFiled 2001·Application pending·0 cites
- 2644US2006135515A1Heterocyclic amides and their use treating thromboembolic diseases and tumorsDORSCH DIETER·Filed 2003·Application pending·0 cites
- 2743US2010210864A1Process for the preparation of n-arylmorpholinonesDORSCH DIETER·Filed 2010·Application pending·0 cites
- 2843US2005171102A1Semicarbazide derivatives for combating thromboembolic diseasesFiled 2003·Application pending·0 cites
- 2943US2005203127A12-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thrombosesFiled 2003·Application pending·0 cites
- 3043US2005176760A1N-'4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseasesMERCK PATENT GMBH·Filed 2003·Application pending·0 cites
- 3142US7902223B2Phenyl derivatives as factor XA inhibitorsMERCK PATENT GMBH·Filed 2002·Granted Mar 8, 2011·0 cites·26 claims
- 3242US2007265259A1Proline DerivativesMEDERSKI WERNER·Filed 2005·Application pending·0 cites
- 3342US2007161623A1Urea derivativesMERCK PATENT GMBH·Filed 2005·Application pending·0 cites
- 3440US2004082563A1Phenyl derivatives 3Filed 2002·Application pending·0 cites
- 3540US2004092517A1Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumoursFiled 2002·Application pending·0 cites
- 3640US2004220411A1Oxalic acid derivativesFiled 2002·Application pending·0 cites
- 3737US8093240B2Triazole derivativesCEZANNE BERTRAM·Filed 2006·Granted Jan 10, 2012·0 cites·2 claims
- 3837US2005119316A1Semicarbazide derivatives and the use thereof as antithromboticsMERCH PATENT GMBH·Filed 2003·Application pending·0 cites
- 3937US2004093170A1Method for determining pharmaceutically active substancesFiled 2002·Application pending·0 cites
- 4035US2008003214A1Medicaments Comprising Carbonyl Compounds, And The Use ThereofCEZANNE BERTRAM·Filed 2005·Application pending·0 cites
- 4135US2008081814A1Carbonyl Compounds Which Can be Used as Inhibitors of Coagulation Factor XaCEZANNE BERTRAM·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bertram Cezanne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →